Lymphocyte depleted Hodgkin lymphoma: An evaluation with immunophenotyping and genetic analysis

Leukemia and Lymphoma

Volumn 50, Issue 6, 2009, Pages 937-943

  Slack, Graham W ^a   Ferry, Judith A ^a   Hasserjian, Robert P ^a   Sohani, Aliyah R ^a   Longtine, Janina A ^b,c   Harris, Nancy L ^a   Zukerberg, Lawrence R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Classical Hodgkin lymphoma; Immunoglobulin gene rearrangement; Immunophenotype; Lymphocyte depleted Hodgkin lymphoma; Morphologic features

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CD15 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CELL PROTEIN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; FASCIN; INTERFERON REGULATORY FACTOR 4; MELAN A; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN IGH; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROBLAST; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPH NODE BIOPSY; LYMPHOCYTE; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; MALE; PLEURA BIOPSY; PRIORITY JOURNAL; REED STERNBERG CELL;

ADULT; AGED; ANTIGENS, CD15; ANTIGENS, CD30; B-CELL-SPECIFIC ACTIVATOR PROTEIN; CARRIER PROTEINS; FEMALE; GENE REARRANGEMENT; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; INTERFERON REGULATORY FACTORS; LYMPHOCYTES; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; REED-STERNBERG CELLS;

EID: 68449083857     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902930488     Document Type: Article

References (33)

1. Lukes R, Butler J, Hicks E. Natural history of Hodgkin's disease as related to its pathological picture. Cancer 1966;19:317-344.
2. Benharroch D, SteinH, Peh S-C. Lymphocyte-depleted classical Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe SE, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008. p 334.
3. Delsol G, Gatter KC, Stein H, Erber WN, Pulford KA, Zinne K, Mason DY. Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet 1984;2:1124-1129.
4. Hall PA, D'Ardenne AJ. Value of CD15 immunostaining in diagnosing Hodgkin's disease: A review of published literature. J Clin Pathol 1987;40:1298-1304.
5. Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said JW. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol 1997;150:543-562.
6. Schmid C, Pan L, Diss T, Isaacson P. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 1991;139:701-707.
7. Stein H, Lennert K, Feller A, Mason D. Immunological analysis of tissue sections in diagnosis of lymphoma. In: Hoffbrand AV, editor. Recent Advances in Haematology. New York: Churchill Livingstone; 1985. pp 127-169.
8. Strauchen JA. Leucocyte common antigen in the differential diagnosis of Hodgkin's disease. Hematol Oncol 1989;7:149-153.
9. Zukerberg L, Collins A, Ferry J, Harris N. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 1991;139:475-483.
10. Steimle-Grauer SA, Tinguely M, Seada L, Fellbaum C, Hansmann ML. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. Virchows Arch 2003;442:284-293.
11. Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: A novel pan pre-B and B-cell marker. Am J Surg Pathol 2002;26:1343-1350.
12. Ponzoni M, Arrigoni G,Doglioni C.New transcription factors in diagnostic hematopathology. Adv Anat Pathol 2007;14:25-35.
13. Carbone A, Gloghini A, Aldinucci D, Gattei V, Dalla-Favera R, Gaidano G. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease. Br J Haematol 2002;117:366-372.
14. Foss H-D, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its Bcell origin. Blood 1999;94:3108-3113.
15. Saez AI, Artiga MJ, Sanchez-Beato M, Sanchez-Verde L, Garcia JF, Camacho FI, Franco R, Piris MA. Analysis of octamer-binding transcription factors Oct 2 and Oct 1 and their coactivator BOB.1/OBF.1 in lymphomas. Mod Pathol 2002;15:211-220.
16. Stein H, Marafioti T, Foss HD, Laumen H, Hummel M, Anagnostopoulos I, Wirth T, Demel G, Falini B. Downregulation of BOB.1/OBF.1 and Oct 2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001;97:496-501.
17. Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL, Piccaluga PP, Pileri A Jr, Giunti M, Falini B, Bolis GB, Stein H. Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol 2002;55:162-176.
18. Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He WW, Ricciardi-Castagnoli P, Rosen CA, Carter KC. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999;94:411-416.
19. Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, Stein H. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000;95: 1443-1450.
20. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, HummelM, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
21. Greer JP, Kinney MC, Cousar JB, Flexner JM, Dupont WD, Graber SE, Greco FA, Collins RD, Stein RS. Lymphocytedepleted Hodgkin's disease. Clinicopathologic review of 25 patients. Am J Med 1986;81:208-214.
22. Kant J, Hubbard S, Longo D, Simon R, DeVita V, Jaffe E. The pathologic and clinical heterogeneity of lymphocytedepleted Hodgkin's disease. J Clin Oncol 1986;4:284-294.
23. Neiman RS, Rosen PJ, Lukes RJ. Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity. N Engl J Med 1973;288:751-755.
24. Mhawech-Fauceglia P, Saxena R, Zhang S, Terracciano L, Sauter G, Chadhuri A, Herrmann FR, Penetrante R. Pax-5 immunoexpression in various types of benign and malignant tumours: A high-throughput tissue microarray analysis. J Clin Pathol 2007;60:709-714.
25. Garcia-Cosio M, Santon A, Martin P, Camarasa N, Montalban C, Garcia JF, Bellas C, Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol 2004;17: 1531-1538.
26. Tzankov A, Zimpfer A, Pehrs AC, Lugli A, Went P, Maurer R, Pileri S, Dirnhofer S. Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003;16:1141-1147.
27. McCune RC, Syrbu SI, Vasef MA. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: A comparative study using high throughput tissue microarrays. Mod Pathol 2006;19:1010-1018.
28. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-Bcell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol 2003;120:767-777.
29. Tzankov A, Bourgau C, Kaiser, A, Zimpfer A, Maurer R, Pileri SA, Went P, Dirnhofer S. Rare expression of T-cell markers in classical Hodgkin's lymphoma. Mod Pathol 2005;18:1542-1549.
30. Stein H, Delsol G, Pileri SA, Weiss LM, Poppema S, Jaffe ES. Classical Hodgkin lymphoma, introduction. In: Swerdlow SH, Campo E, Harris NL, Jaffe SE, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008. pp 326-329.
31. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virusassociated Hodgkin's lymphoma. Br J Haematol 2004;125: 267-281.
32. Chute DJ, Cousar JB, MahadevanMS, Siegrist KA, Silverman LM, Stoler MH. Detection of immunoglobulin heavy chain gene rearrangements in classic Hodgkin lymphoma using commercially available BIOMED-2 primers. Diagn Mol Pathol 2008;17:65-72.
33. Jaffe ES, Stein H, Swerdlow SH, Campo E, Pileri SA, Harris NL. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe SE, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008. pp 267-268.